The senators commented on the continuing need for solutions to the drug shortage crisis. Sen. Klobuchar discussed the introduction of the Preserving Access to Life-Saving Medications Act, which would require drug manufacturers to provide early notification to the FDA whenever a shortage may occur. She said this requirement would help the FDA to work with pharmacy groups, drug manufacturers and healthcare providers on managing and preparing for shortages.
She said the bill also requires the FDA to develop an evidence-based list of drugs that are vulnerable to shortages. The FDA would then work with manufacturers to plan for potential problems that could result in a shortage.
ASA continues to support the bill, S. 296, and other efforts to combat drug shortages.
Related Articles on Anesthesia:
Type of Lipid Emulsion Affects Reversal of Toxicity From Local Anesthetics
Oregon Returns Supply of Lethal Injection Drugs, Turning Spotlight on Drug Companies
Somnia Anesthesia’s Hugh Morgan Discusses Expectations for Anesthesia in New Video
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
